Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

RxSight (RXST) Leases (2020 - 2025)

RxSight's Leases history spans 6 years, with the latest figure at $10.0 million for Q4 2025.

  • For Q4 2025, Leases fell 11.22% year-over-year to $10.0 million; the TTM value through Dec 2025 reached $10.0 million, down 11.22%, while the annual FY2025 figure was $10.0 million, 11.22% down from the prior year.
  • Leases reached $10.0 million in Q4 2025 per RXST's latest filing, down from $10.3 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $11.2 million in Q4 2024 to a low of $2.1 million in Q1 2024.
  • Average Leases over 5 years is $6.3 million, with a median of $4.6 million recorded in 2021.
  • Peak YoY movement for Leases: tumbled 42.28% in 2024, then skyrocketed 432.26% in 2025.
  • A 5-year view of Leases shows it stood at $4.3 million in 2021, then dropped by 7.96% to $3.9 million in 2022, then tumbled by 38.02% to $2.4 million in 2023, then skyrocketed by 358.96% to $11.2 million in 2024, then decreased by 11.22% to $10.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Leases are $10.0 million (Q4 2025), $10.3 million (Q3 2025), and $10.6 million (Q2 2025).